TOP 10 AMONG

One of the largest distributors in Russia.

Our objective is to render maximum assistance in preserving the health and increasing the lifespan of Russian patients. GDP strives to make cutting-edge medical developments available to this country’s population in the shortest possible time frame.

538

employees

323

direct contracts

6

years of successful wholesale supply operations

Participant of the
14 High-Cost Nosologies state programme

Partner of the Ministry of Health of Russian Federation and regional healthcare departments

Mission

To provide the healthcare system of the Russian Federation with effective pharmaceuticals, modern medical equipment and quality medical products.

Wide range
of innovative products

Product
safety

Adherence
to deadlines

Regional
coverage

Technological leadership
in warehouse logistics

GOOD
DISTRIBUTION
PARTNERS

2016

2019

2020

2021

2022

2025

GDP takes over a 30,300 sq m office-and-warehouse complex for medication wholesale. The complex is located in the Belye Stolby micro-district in the Domodedovsky District of the Moscow Region, within the South Gate industrial park.

At year-end, GDP holds a 2.7% market share according to analytical company RNC Pharma

GDP wins the bidding to supply the Ministry of Health with Alemtuzumab for disseminated sclerosis patients within the 14 High-Cost Nosologies programme, under a contract worth RUB 573.4 mn.

GDP has entered the Top 5 distributors in the segment of public procurement of medicinal products, accounting for 3.8 % of the market share, according to the DSM report.

A diploma was received in the Platinum Ounce category “For active growth and development of competition in the public procurement segment.”

A major Russian investment fund has announced cooperation between Russia and Vietnam in the pharmaceutical sector.

Development strategy

To become an industry leader by 2030, offering the most effective comprehensive solutions for the implementation of national healthcare projects.

To develop the state-financed line of business and to increase regional presence

To expand into all segments of the state-financed market with a focus on procurement for compulsory health insurance